Stevens-Johnson syndrome, toxic epidermal necrolysis and phenytoin. Factors linked to a higher risk;Síndrome de Stevens-Johnson, necrólisis epidérmica tóxica y fenitoína. Factores asociados a un aumento del riesgo

Revista de Neurologia

Volumn 38, Issue 11, 2004, Pages 1056-1060

  Gómez Criado, María S ^a,b   Ayani, I ^a   Leon Colombo T ^a   Ramos, M L ^a   Reneses, M J ^a  

^a PFIZER INC   (United States)

^b NONE   (Spain)

Author keywords

Antiepileptic drugs; Corticoids; Phenytoin; Radiotherapy; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALPRAZOLAM; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CORTICOSTEROID; DEXAMETHASONE; GABAPENTIN; LABETALOL; LEVOFLOXACIN; NYSTATIN; OMEPRAZOLE; PARACETAMOL; PHENYTOIN; TAMOXIFEN; TRIMETAZIDINE; VALPROIC ACID;

ADULT; AGED; ANTICONVULSANT THERAPY; BRAIN METASTASIS; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG CHOICE; DRUG SURVEILLANCE PROGRAM; EPILEPSY; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; RASH; REVIEW; RISK FACTOR; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 3843090436     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3811.2004018     Document Type: Review

References (30)

1. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-85.
2. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Rojeau JC. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol 2002; 138: 1019-24.
3. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600-7.
4. Rzany B, Correira O, Kelly JP, Naldi L, Auquier A, Stern R. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Lancet 1999; 353: 2190-4.
5. Micali G, Linthicum K, Han N, West DP. Increased risk of erythema multiforme major with combination of anticonvulsant and radiation therapies. Pharmacotherapy 1999; 19: 223-7.
6. Delattre JY, Safai B, Posner JB. Erythema multiforme and Stevens-Johnson syndrome in patients receiving cranial irradiation and phenytoin. Neurology 1988; 38: 194-8.
7. Eralp Y, Aydiner A, Tas F, Saip P, Topuz E. Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation. Am J Clin Oncol 2001; 24: 347-50.
8. Khafaga YM, Jamshed A, Allam AA, Mourad WA, Ezzat A, Al Eisa A, et al. Stevens-Johnson syndrome in patients on phenytoin and cranial radiotherapy. Acta Oncol 1999; 38: 111-6.
9. Cohen AD, Reichental E, Halevy S. Phenytoin-induced severe cutaneous drug reactions: suspected interactions with corticosteroids and H2-blockers. Isr Med Assoc J 1999; 1: 95-7.
10. Mishriki Y. The case of the dire desquamation. Postgrad Med 1998; 103: 187-8.
11. Frangogiannis NG, Boridy I, Mazhar M, Mathews R, Gangopadhyay S, Cate T. Cyclophosphamide in the treatment of toxic epidermal necrolysis. South Med J 1996; 89: 1001-3.
12. Saghari S, Bakshandch H, Kerdel F. Sudden onset of melanuria in a patient with metastatic melanoma and toxic epidermal necrolysis. Int J Dermatol 2002; 41: 116-8.
13. Mamon HJ, WEn PY, Burns AC, Loeffler JS. Allergic skin reactions to anticonvulsivant medications in patients receiving cranial irradiation. Epilepsia 1999; 40: 341-4.
14. Bachot N, Rojeau JC. Physiopathology and treatment of severe drug reactions. Curr Opin Allergy Clin Immunol 2001; 1: 293-8.
15. Preuss L. Allergic reactions to systemic glucocorticoids: a review. Ann Allergy 1985; 55: 772-5.
16. Lauerma AI, Reitamo S, Maibach HI. Systemic hydrocortisone/cortisol induces allergic skin reactions in presensitized subjects. J Am Acad Dermatol 1991; 24: 182-5.
17. Hoang-Xuan K, Delattre JY, Poisson M. Stevens-Johnson syndrome in a patient receiving cranial irradiation and carbamazepine. Neurology 1990; 40: 1144-5.
18. Chevenet C, Ferrier M, Reverte M, Tao Y, Perea R, Roger H, et al. Erythème polymorphe du a l'association carbamazepine et irradiation cérébrale. Ann Dermatol Venereol 1992; 119: 929-31.
19. Weltman E, Salvajoli JV. Stevens-Johnson syndrome resulting from whole-brain irradiation and phenytoin [letter]. Am J Oncol 1996; 19: 431.
20. Duncan KO, Tigelaar RE, Bolagnia JL. Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving Phenobarbital. J Am Acad Dermatol 1999; 40: 493-6.
21. De Juan-Martín F, Bouthelier-Moreno M, Marín-Bravo MC, Melendo-Gimeno J. Necrólisis epidérmica tóxica tratada con inmunoglobulina intravenosa. An Esp Pediatr 2002; 56: 370.
22. Sachs B, Ronnau AC, Ruzicka T, Gleichmann E, Schuppe. Lamotrigine and toxic epidermal necrolysis [letter]. Lancet 1996; 348: 1597.
23. Page RL II, O'Neil MG, Yarbrough DR III, Conradi S. Fatal toxic epidermal necrolysis related to lamotrigine administration. Pharmacotherapy 1998; 18: 392-8.
24. Chaffin JJ, Davis SM. Suspected lamotrigine-induced toxic epidermal necrolysis. Ann Pharmacother 1997; 31: 720-3.
25. Vukelic D, Bozinovic D, Tesovic G, Dobric I, Loncaric D, Knezovic, et al. Lamotrigine and toxic epidermal necrolysis. Dermatology 1997; 195: 307.
26. Wadelius M, Karlsson T, Wadelius C, Rane. Lamotrigine and toxic epidermal necrolysis. Lancet 1996; 348: 1041.
27. Reents SB, Luginbuhl WE, Davis SM. Phenytoin-carbamazepine cross-sensitivity. DICP 1989; 23: 235-6.
28. Tsai S-J. Valproic acid-induced Stevens-Johnson syndrome. J Clin Psychopharmacol 1998; 18: 420.
29. Detoledo JC, Minagar A, Lowe MR, Ramsay RE. Skin eruption with gabapentin in a patient with repeated AED-induced Stevens-Johnson syndrome. Ther Drug Monit 1999; 21: 137-8.
30. Gonzáles-Sicilia L, Cano A, Serrano M, Hernández. Stevens-Johnson syndrome associated with gabapentin [letter]. Am J Med 1998; 105: 455.